SANTA MONICA, Calif., Dec. 5, 2016 /PRNewswire/ -- Parallax Health Sciences, Inc. ("Parallax" or the "Company") (OTC PINK: PRLX), is pleased to announce that its pharmaceutical business, RoxSan Pharmacy, Inc. has received a license to serve Medicare B clients, allowing coverage in all of the 42 states it is currently licensed to do business in.
Michael Rashti Pharm. D, Pharmacist in Charge at RoxSan Pharmacy, says, "This is a very exciting for our business. Medicare B spending last year came to roughly $170 Billion, accounting for about 14% of all Medicare Spending. This dramatically expands our potential client base while allowing RoxSan to deliver world-class services and products to a much wider audience geographically. Securing this Medicare Part B license also moves Parallax a big step closer to our goal of becoming health insurance agnostic. We want to serve anyone with a need, regardless of Insurance provider."
Having Medicare Part B coverage also allows for other Parallax products to be offered through RoxSan Pharmacy. The perfect synergies of the Parallax divisions will provide better patient care, while expanding the patient population the company can serve.
ABOUT MEDICARE PART B
Medicare Part B ("Part B") covers services (like lab tests, surgeries, and doctor visits) and supplies (like wheelchairs and walkers) considered medically necessary to treat a disease or condition.
"Part B" covers things like:
RoxSan Pharmacy, Inc. is a wholly owned subsidiary of Parallax Health Sciences, Inc. a publicly traded healthcare company under the symbol "PRLX" on the OTC Market. RoxSan Pharmacy, Inc. is a 60 year old Beverly Hills, CA based Pharmacy specializing in Compound prescriptions and infertility treatments. RoxSan Pharmacy is licensed in 42 States in the US.
www.roxsan.com
ABOUT PARALLAX HEALTH SCIENCES, INC.
Parallax Health Sciences, Inc. ("Parallax Health") is an innovative biomedical health-care company headquartered in Santa Monica, California, which operates under three divisions: Pharmaceuticals, Diagnostics, and Remote Patient Monitoring. Each of these three divisions target a separate vertical market that are synergistic, compliment and strengthen each other and our value proposition as a whole.
Parallax Health's primary goal since inception has been to develop, license and or acquire, quality products and deliver those to our customers, patients, payers, health care facilities and providers, in the US and around the world. It is the mission behind the founding of Parallax that we strive at all times to identify products, services and technologies that deliver solutions and fill the void in the current market for high quality, high efficacy products and services delivered at reasonable and rational prices.
www.parallaxhealthsciences.com
QOLPOM, Inc. ("QOLPOM") is our Tucson, AZ based systems integration company, providing Telehealth and remote patient monitoring ("RPM") solutions to the major stakeholders in the healthcare industry through its novel platform. QOLPOM's platform was designed to provide the flexibility to work with clients existing IT infrastructure and systems, while delivering scalability through its cloud based software.
www.qolpom.com
Parallax Diagnostics, Inc. is our Santa Monica, CA based point of care diagnostic testing company focused on the exploitation of a proprietary diagnostic device for the areas of Infectious Diseases, Cardiac Markers, Drugs of Abuse tests and various other medical conditions. The Company has patented and patent pending diagnostic testing devices, and tests that include a previously FDA Cleared 510K desktop analyzer for both qualitative and quantitative assays and twenty-four FDA 510K-previously cleared diagnostic tests. The Company plans to develop a novel CD4-8 Rapid Immune Status test targeting the HIV/AIDS/TB treatment and monitoring market.
Advertisement
Michael Rashti Pharm. D, Pharmacist in Charge at RoxSan Pharmacy, says, "This is a very exciting for our business. Medicare B spending last year came to roughly $170 Billion, accounting for about 14% of all Medicare Spending. This dramatically expands our potential client base while allowing RoxSan to deliver world-class services and products to a much wider audience geographically. Securing this Medicare Part B license also moves Parallax a big step closer to our goal of becoming health insurance agnostic. We want to serve anyone with a need, regardless of Insurance provider."
Advertisement
Having Medicare Part B coverage also allows for other Parallax products to be offered through RoxSan Pharmacy. The perfect synergies of the Parallax divisions will provide better patient care, while expanding the patient population the company can serve.
ABOUT MEDICARE PART B
Medicare Part B ("Part B") covers services (like lab tests, surgeries, and doctor visits) and supplies (like wheelchairs and walkers) considered medically necessary to treat a disease or condition.
"Part B" covers things like:
- Clinical research
- Ambulance services
- Durable medical equipment (DME)
- Mental health
- Inpatient
- Outpatient
- Partial hospitalization
- Getting a second opinion before surgery
- Limited outpatient prescription drugs
RoxSan Pharmacy, Inc. is a wholly owned subsidiary of Parallax Health Sciences, Inc. a publicly traded healthcare company under the symbol "PRLX" on the OTC Market. RoxSan Pharmacy, Inc. is a 60 year old Beverly Hills, CA based Pharmacy specializing in Compound prescriptions and infertility treatments. RoxSan Pharmacy is licensed in 42 States in the US.
www.roxsan.com
ABOUT PARALLAX HEALTH SCIENCES, INC.
Parallax Health Sciences, Inc. ("Parallax Health") is an innovative biomedical health-care company headquartered in Santa Monica, California, which operates under three divisions: Pharmaceuticals, Diagnostics, and Remote Patient Monitoring. Each of these three divisions target a separate vertical market that are synergistic, compliment and strengthen each other and our value proposition as a whole.
Parallax Health's primary goal since inception has been to develop, license and or acquire, quality products and deliver those to our customers, patients, payers, health care facilities and providers, in the US and around the world. It is the mission behind the founding of Parallax that we strive at all times to identify products, services and technologies that deliver solutions and fill the void in the current market for high quality, high efficacy products and services delivered at reasonable and rational prices.
www.parallaxhealthsciences.com
QOLPOM, Inc. ("QOLPOM") is our Tucson, AZ based systems integration company, providing Telehealth and remote patient monitoring ("RPM") solutions to the major stakeholders in the healthcare industry through its novel platform. QOLPOM's platform was designed to provide the flexibility to work with clients existing IT infrastructure and systems, while delivering scalability through its cloud based software.
www.qolpom.com
Parallax Diagnostics, Inc. is our Santa Monica, CA based point of care diagnostic testing company focused on the exploitation of a proprietary diagnostic device for the areas of Infectious Diseases, Cardiac Markers, Drugs of Abuse tests and various other medical conditions. The Company has patented and patent pending diagnostic testing devices, and tests that include a previously FDA Cleared 510K desktop analyzer for both qualitative and quantitative assays and twenty-four FDA 510K-previously cleared diagnostic tests. The Company plans to develop a novel CD4-8 Rapid Immune Status test targeting the HIV/AIDS/TB treatment and monitoring market.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/parallax-achieves-major-milestone-with-license-to-serve-medicare-part-b-patients-through-its-roxsan-subsidiary-across-42-states-300373012.html
SOURCE Parallax Health Sciences, Inc.
